ERAMET (ERA.PA) Fundamental Analysis & Valuation

EPA:ERA • FR0000131757

Current stock price

49.38 EUR
-0.08 (-0.16%)
Last:

This ERA.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ERA.PA Profitability Analysis

1.1 Basic Checks

  • ERA had negative earnings in the past year.
  • ERA had a negative operating cash flow in the past year.
  • ERA had positive earnings in 4 of the past 5 years.
  • ERA had a positive operating cash flow in 4 of the past 5 years.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.58%, ERA is doing worse than 66.67% of the companies in the same industry.
  • The Return On Equity of ERA (-9.29%) is worse than 74.36% of its industry peers.
  • With a Return On Invested Capital value of 0.84%, ERA is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for ERA is in line with the industry average of 8.58%.
  • The 3 year average ROIC (7.61%) for ERA is well above the current ROIC(0.84%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROIC 0.84%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

  • In the last couple of years the Profit Margin of ERA has declined.
  • ERA has a worse Operating Margin (1.91%) than 64.10% of its industry peers.
  • ERA's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 68.15%, ERA belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • ERA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.91%
PM (TTM) N/A
GM 68.15%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ERA.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ERA is destroying value.
  • The number of shares outstanding for ERA has been increased compared to 1 year ago.
  • ERA has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ERA has been reduced compared to a year ago.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • ERA has an Altman-Z score of 1.07. This is a bad value and indicates that ERA is not financially healthy and even has some risk of bankruptcy.
  • ERA's Altman-Z score of 1.07 is on the low side compared to the rest of the industry. ERA is outperformed by 79.49% of its industry peers.
  • A Debt/Equity ratio of 2.03 is on the high side and indicates that ERA has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.03, ERA is not doing good in the industry: 87.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACC0.09
WACC9.27%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • ERA has a Current Ratio of 1.54. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ERA (1.54) is worse than 61.54% of its industry peers.
  • ERA has a Quick Ratio of 1.06. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
  • ERA has a Quick ratio (1.06) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.06
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ERA.PA Growth Analysis

3.1 Past

  • ERA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -219.63%.
  • ERA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.00% yearly.
  • ERA shows a decrease in Revenue. In the last year, the revenue decreased by -6.91%.
  • ERA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.39% yearly.
EPS 1Y (TTM)-219.63%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%

3.2 Future

  • ERA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -55.03% yearly.
  • ERA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.17% yearly.
EPS Next Y-333.81%
EPS Next 2Y-53.42%
EPS Next 3Y-6.49%
EPS Next 5Y-55.03%
Revenue Next Year4.29%
Revenue Next 2Y6.01%
Revenue Next 3Y6.87%
Revenue Next 5Y6.17%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

0

4. ERA.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ERA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 54.23, ERA can be considered very expensive at the moment.
  • 71.79% of the companies in the same industry are cheaper than ERA, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, ERA is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 54.23
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ERA is valued a bit more expensive than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.27
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

  • ERA's earnings are expected to decrease with -6.49% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-53.42%
EPS Next 3Y-6.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ERA.PA Dividend Analysis

5.1 Amount

  • ERA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ERA.PA Fundamentals: All Metrics, Ratios and Statistics

ERAMET

EPA:ERA (3/27/2026, 7:00:00 PM)

49.38

-0.08 (-0.16%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-18
Earnings (Next)04-23
Inst Owners14.01%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.42B
Revenue(TTM)2.88B
Net Income(TTM)-97.00M
Analysts80
Price Target55.28 (11.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP-44.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.12%
PT rev (3m)2.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-28%
EPS NY rev (3m)2.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.29%
Revenue NY rev (3m)5.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 54.23
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 2.63
EV/EBITDA 14.27
EPS(TTM)-3.42
EYN/A
EPS(NY)0.91
Fwd EY1.84%
FCF(TTM)-25.76
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS100.31
BVpS36.3
TBVpS18.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROCE 1.16%
ROIC 0.84%
ROICexc 0.99%
ROICexgc 1.13%
OM 1.91%
PM (TTM) N/A
GM 68.15%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexgc growth 3Y-56.22%
ROICexgc growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Debt/EBITDA 10.29
Cap/Depr 403.31%
Cap/Sales 21.11%
Interest Coverage 0.34
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.06
Altman-Z 1.07
F-Score2
WACC9.27%
ROIC/WACC0.09
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-219.63%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
EPS Next Y-333.81%
EPS Next 2Y-53.42%
EPS Next 3Y-6.49%
EPS Next 5Y-55.03%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%
Revenue Next Year4.29%
Revenue Next 2Y6.01%
Revenue Next 3Y6.87%
Revenue Next 5Y6.17%
EBIT growth 1Y-51.75%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year-4.34%
EBIT Next 3Y30.08%
EBIT Next 5Y23.12%
FCF growth 1Y-850%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.46%
OCF growth 3YN/A
OCF growth 5YN/A

ERAMET / ERA.PA Fundamental Analysis FAQ

What is the fundamental rating for ERA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ERA.PA.


Can you provide the valuation status for ERAMET?

ChartMill assigns a valuation rating of 0 / 10 to ERAMET (ERA.PA). This can be considered as Overvalued.


Can you provide the profitability details for ERAMET?

ERAMET (ERA.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for ERA stock?

The dividend rating of ERAMET (ERA.PA) is 0 / 10 and the dividend payout ratio is -44.33%.